phosphoserine has been researched along with Cardiomyopathies in 1 studies
Phosphoserine: The phosphoric acid ester of serine.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarma, S | 1 |
| Li, N | 1 |
| van Oort, RJ | 1 |
| Reynolds, C | 1 |
| Skapura, DG | 1 |
| Wehrens, XH | 1 |
1 other study available for phosphoserine and Cardiomyopathies
| Article | Year |
|---|---|
Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy.
Topics: Aging; Animals; Calcium; Cardiomyopathies; Cyclic AMP-Dependent Protein Kinases; Death, Sudden; Fibr | 2010 |